0000899243-18-018319.txt : 20180627
0000899243-18-018319.hdr.sgml : 20180627
20180627162531
ACCESSION NUMBER: 0000899243-18-018319
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180625
FILED AS OF DATE: 20180627
DATE AS OF CHANGE: 20180627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: BYERS BLAKE
CENTRAL INDEX KEY: 0001741840
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38541
FILM NUMBER: 18922042
MAIL ADDRESS:
STREET 1: C/O MAGENTA THERAPEUTICS
STREET 2: 50 HAMPSHIRE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Magenta Therapeutics, Inc.
CENTRAL INDEX KEY: 0001690585
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 857-201-2700
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
STREET 2: 4TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-06-25
0
0001690585
Magenta Therapeutics, Inc.
MGTA
0001741840
BYERS BLAKE
C/O MAGENTA THERAPEUTICS, INC.
50 HAMPSHIRE STREET
CAMBRIDGE
MA
02139
1
0
0
0
Common Stock
2018-06-25
4
C
0
3339137
A
3339137
I
See Footnote
Series A Preferred Stock
2018-06-25
4
C
0
133400
D
Common Stock
51626
0
I
See Footnote
Series B Preferred Stock
2018-06-25
4
C
0
8494864
D
Common Stock
3287511
0
I
See Footnote
The reported securities converted into shares of the Issuer's common stock on a 2.58398:1 basis automatically immediately prior to the closing of the Issuer's initial public without payment of further consideration. The shares had no expiration date.
The reported securities are directly held by GV 2016, L.P. GV 2016 GP, L.P., the general partner of GV 2016, L.P., GV 2016 GP, L.L.C., the general partner of GV 2016 GP, L.P., Alphabet Holdings LLC, the sole member of GV 2016 GP, L.L.C., XXVI Holdings Inc., the managing member of Alphabet Holdings LLC, and Alphabet Inc., the sole stockholder of XXVI Holdings Inc., may each be deemed to have sole power to vote or dispose of these shares. Dr. Byers is an affiliate of GV 2016 GP, L.P. but does not have voting or dispositive power over the shares held by GV 2016, L.P. Dr. Byers disclaims beneficial ownership of the shares held by GV 2016, L.P. except to the extent of his pecuniary interest, if any, therein and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for the purpose of Section 16 or for any other purpose.
/s/ Zoran Zdraveski, Attorney-in-Fact for Blake Byers
2018-06-27